Search Details

Word: breasted (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...late-night TV, Conan fantasized about a 24-hour breastfeeding channel. Madonna, however, clearly would not be a subscriber; frustrated by the pains of lactation, she pounded her fist during a recent interview to yell, "There will be life after breast feeding...

Author: By Soman S. Chainani, CRIMSON STAFF WRITER | Title: Soman's in the (K)now | 10/20/2000 | See Source »

Ahhh. The breast of times, the worst of times...

Author: By Soman S. Chainani, CRIMSON STAFF WRITER | Title: Soman's in the (K)now | 10/20/2000 | See Source »

Nine-year-old Phylicia Dryer wants to be a pop star. Growing up in a music industry that has no qualms about the ethics of exploiting the very young, Phylicia's dreams of becoming the next Britney Spears may only be a hop, skip and breast implant away. As the youngest member of BreZe, a pre-teen pop-music foursome dubbed the Spice Babies (their combined age is 41), Phylicia already has Bill Kimber (who discovered Eurythmics) as her manager, as well as a share of a $1.5 million contract with Warner Brothers. She's tipped to be the biggest...

Author: By Yan Fang, CONTRIBUTING WRITER | Title: The Boys (and Girls) Are Back in Town | 10/20/2000 | See Source »

BOOSTER SHOT Patients undergoing radiation for breast cancer are always happy when the last treatment is over. But now a study of 5,500 women shows that more radiation--eight additional sessions--can cut in half the odds that the cancer will recur in the same breast. Younger women show an even greater benefit from the booster dose. A drawback: more radiation may mean a greater chance of breast deformity...

Author: /time Magazine | Title: Your Health: Oct. 2, 2000 | 10/2/2000 | See Source »

Consider the plight of biotech firm Genentech in the early '90s. It had four promising drugs that it wanted to take into clinical trials one year, but it had resources for only three. On the bubble: the breast-cancer drug Herceptin. The R.-and-D. tax credit provided funds for Genentech to proceed with that fourth drug, which came to market last year and is now saving lives while ringing up sales of $75 million a quarter. With the tax credit, says Walter Moore, vice president of government affairs at Genentech, his company is able to pursue one additional drug...

Author: /time Magazine | Title: Hooray For R. and D. | 9/25/2000 | See Source »

Previous | 259 | 260 | 261 | 262 | 263 | 264 | 265 | 266 | 267 | 268 | 269 | 270 | 271 | 272 | 273 | 274 | 275 | 276 | 277 | 278 | 279 | Next